Michael Marberger

Medical University of Vienna

Papers

2

Total Citations

150

H-Index

2

About

Michael Marberger is a pioneering figure in urologic oncology, whose career has been defined by a commitment to advancing minimally invasive surgical techniques and refining treatment paradigms for kidney and prostate cancers. His research critically evaluates the shifting landscape of renal cell carcinoma management, most notably through his landmark 2009 paper analyzing the roles of minimally invasive surgery and active surveillance (147 citations). This work has been instrumental in guiding clinicians toward more conservative, patient-tailored approaches, reducing overtreatment of small renal masses. Marberger’s contributions extend to the comparative safety of robotic-assisted radical prostatectomy, where he has provided nuanced assessments of surgical outcomes. A former chairman of the Department of Urology at the Medical University of Vienna, he has also been a driving force in the European Association of Urology guidelines, shaping international standards for prostate and kidney cancer care. With a career spanning over four decades, his influence is reflected not only in his citation impact but in the countless surgeons he has trained and the evidence-based shifts he has championed—making him a true architect of modern urologic practice.

Research Focus

Key Achievements

2
H-Index
2
Papers
150
Total Citations
75
Avg Citations/Paper
🏆 Most Cited Paper
A Critical Analysis of the Actual Role of Minimally Invasive Surgery and Active Surveillance for Kidney Cancer
147 citations · 2009
📈 Most Prolific Year: 2009 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Medical University of Vienna

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago